PubMed

Infections in patients with chronic lymphocytic leukemia treated with fludarabine.

Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, Keating MJ.

Ann Intern Med. 1998 Oct 1;129(7):559-66.PMID: 9758577 [PubMed - indexed for MEDLINE]Related articlesFree article

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

O'Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M.

Blood. 1993 Sep 15;82(6):1695-700.PMID: 8400226 [PubMed - indexed for MEDLINE]Related articlesFree article

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.

Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M.

Ann Intern Med. 1992 Sep 15;117(6):466-9.PMID: 1354425 [PubMed - indexed for MEDLINE]Related articles

Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.

Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA.

J Clin Oncol. 2001 Aug 15;19(16):3611-21.PMID: 11504743 [PubMed - indexed for MEDLINE]Related articles

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.

Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA.

N Engl J Med. 2000 Dec 14;343(24):1750-7.PMID: 11114313 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.

Johnson S, Smith AG, Löffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W.

Lancet. 1996 May 25;347(9013):1432-8.PMID: 8676625 [PubMed - indexed for MEDLINE]Related articles

Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.

Eichhorst BF, Busch R, Schweighofer C, Wendtner CM, Emmerich B, Hallek M; German CLL Study Group (GCLLSG).

Br J Haematol. 2007 Jan;136(1):63-72. Epub 2006 Nov 3.PMID: 17083342 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H.

Blood. 1998 Aug 15;92(4):1165-71.PMID: 9694704 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.

Bergmann L, Fenchel K, Jahn B, Mitrou PS, Hoelzer D.

Ann Oncol. 1993 May;4(5):371-5.PMID: 8353071 [PubMed - indexed for MEDLINE]Related articles

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.

Di Raimondo F, Giustolisi R, Lerner S, Cacciola E, O'Brien S, Kantarjian H, Keating MJ.

Ann Oncol. 2001 May;12(5):621-5.PMID: 11432619 [PubMed - indexed for MEDLINE]Related articlesFree article

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia.

O'Brien S, Kantarjian H, Beran M, Koller C, Talpaz M, Lerner S, Keating MJ.

Leukemia. 1997 Oct;11(10):1631-5.PMID: 9324281 [PubMed - indexed for MEDLINE]Related articles

Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.

Perkins JG, Flynn JM, Howard RS, Byrd JC.

Cancer. 2002 Apr 1;94(7):2033-9.PMID: 11932906 [PubMed - indexed for MEDLINE]Related articlesFree article

Late listeriosis after fludarabine plus prednisone treatment.

Girmenia C, Mauro FR, Rahimi S.

Br J Haematol. 1994 Jun;87(2):407-8.PMID: 7947288 [PubMed - indexed for MEDLINE]Related articles

Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.

Hensel M, Kornacker M, Yammeni S, Egerer G, Ho AD.

Br J Haematol. 2003 Aug;122(4):600-6.PMID: 12899715 [PubMed - indexed for MEDLINE]Related articles

Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.

Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.

Semin Oncol. 2000 Apr;27(2 Suppl 5):44-51. Review.PMID: 10877052 [PubMed - indexed for MEDLINE]Related articles

Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia.

Weiss M, Spiess T, Berman E, Kempin S.

Leukemia. 1994 Aug;8(8):1290-3.PMID: 8057664 [PubMed - indexed for MEDLINE]Related articles

Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA.

J Clin Oncol. 2002 Sep 15;20(18):3878-84.PMID: 12228208 [PubMed - indexed for MEDLINE]Related articles

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

Flinn IW, Neuberg DS, Grever MR, Dewald GW, Bennett JM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Moore DF Jr, Tallman MS.

J Clin Oncol. 2007 Mar 1;25(7):793-8. Epub 2007 Feb 5.PMID: 17283364 [PubMed - indexed for MEDLINE]Related articles

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.

Martell RE, Peterson BL, Cohen HJ, Petros WP, Rai KR, Morrison VA, Elias L, Shepherd L, Hines J, Larson RA, Schiffer CA, Hurwitz HI.

Cancer Chemother Pharmacol. 2002 Jul;50(1):37-45. Epub 2002 Apr 27.PMID: 12111110 [PubMed - indexed for MEDLINE]Related articles

Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.

Kasamon YL, Flinn IW, Grever MR, Diehl LF, Garrett-Mayer E, Goodman SN, Lucas MS, Byrd JC.

Clin Cancer Res. 2005 Dec 1;11(23):8413-7.PMID: 16322303 [PubMed - indexed for MEDLINE]Related articlesFree article